Nom du produit:ethyl 4-chloro-2-(methylsulfanyl)pyrimidine-5-carboxylate
IUPAC Name:ethyl 4-chloro-2-(methylsulfanyl)pyrimidine-5-carboxylate
- CAS：5909-24-0
- Formule moléculaire：C8H9ClN2O2S
- Pureté：95%+
- Numéro de catalogue：CM108263
- Poids moléculaire：232.68
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:5909-24-0
- Formule moléculaire:C8H9ClN2O2S
- Point de fusion:-
- Code SMILES:O=C(C1=CN=C(SC)N=C1Cl)OCC
- Densité:
- Numéro de catalogue:CM108263
- Poids moléculaire:232.68
- Point d'ébullition:335.7°C at 760 mmHg
- N° Mdl:MFCD00006085
- Stockage:Keep in inert atmosphere, store at 2-8°C.
Category Infos
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Column Infos
- Cerdulatinib
- Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).
Recherche 
+86 21 5895 0110 
